To cite this paper use one of the standards below:
The Negative Triple Breast Cancer (TNBC), characterized by low expression/absence of detection of hormonal receptors estrogen (ER), progesterone (PR) and growth factors (Her2) is the most common among young women, has the worst prognosis and aggressive characteristics.
Reprogramming the metabolism in tumor cells may provide targets for the treatment of cancer. In TNBC, glutaminase, the first route of metabolism of the glutamine amino acid, has emerged as a promising target.
We evaluated promising compounds in cellular and enzymatic assays to assess tumor selective cytotoxicity and action on the target.
We found that C12 and C15.1 (ChembridgeDIVERSet™ Library) shows promising biochemical results (graphs C and D), and are under further analysis and remodeling of the molecules.
TNBC-MDA-MB-231 and Non-TNBC-SKBR3 cell lines were used, and Glutaminase C (GAC) and Glutamate Dehydrogenase (GDH) were the studied enzymes.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper